Urothelial carcinoma: a case report

Authors

Abstract

Background: the urothelial carcinomas originate from the epithelium of mucous revetment of transitional type and constitute almost totality of the tumors of the excretory, high routes. The primary adenocarcinoma of the urinary tract, are extremely infrequent and they usually have an aggressive behavior, with a shaded prognosis.
Objective: to express the way of presenting a patient with urothelial carcinoma showing some aspects from the sicknesses.
Case report: a 70-years-old male patient, retired, inveterate smoker and with a history of ingesting coffee in large quantities, attended consultation for gross hematuria, lumbar pain, sometimes fixed, other times in the form of ureteral colic and fever of 39 degrees. The analytical study only showed altered lactic dehydrogenase rate. The imaging study with ultrasound showed hydronephrosis and enlarged right ilium with heterogeneous image of 2 cm in the kidney, at the level of the pelvic ureter junction, which was corroborated by computerized axial tomography. The rest of the examinations such as endoscopy, colonoscopy, and cystoscopy of different regions were all negative. Right nephroureterectomy was performed, and the patient is still asymptomatic.
Conclusions: the tumors of the upper urothelium are infrequent neoplasias, in the urinary tract an extraurological origin must be ruled out. The differential diagnosis must be made with the renal cell tumor or the bladder tumor.

DeCS: UROTHELIUM/diagnostic imaging; UROTHELIUM/pathology; CARCINOMA, RENAL CELL/diagnosis; URINARY BLADDER NEOPLASMS/diagnosis; NEPHROURETERECTOMY/methods.

Downloads

Download data is not yet available.

References

1. Ehdaie B, Shariat SF, Savage C, Coleman J, Dalbagn G. Postoperative Nomogram for Disease recurrence and cancer-specific death for upper tract urothelial carcinoma: comparison to American Joint Committee on Cancer Staging Classification. Urology J [Internet]. 2014 [citado 06 Mar 2020];11(2):[aprox. 9 p.]. Disponible en: http://www.urologyjournal.org/index.php/uj/article/view/1891/877

2. Mc Conkey DJ, Choi W, Shen Y, Lee L, Porten S, Matin SF, et al. A Prognostic Gene expression signature in the molecular classification of chemotherapy-naïve urothelial cancer is predictive of clinical outcomes from neoadjuvant chemotherapy: a phase 2 trial of dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin with bevacizumab in urothelial cancer. Eur Urol [Internet]. 2016 [citado 06 Mar 2020];69(5):[aprox. 12 p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4775435/.

3. Ross JS, Wang K, Al-Rohil RN, Nazeer T, Sheehan CE, Otto GA, et al. Advanced urothelial carcinoma: next-generation sequencing reveals diverse genomic alterations and targets of therapy. Modern Pathol [Internet]. 2014 [citado 22 Ago 2019];27(2):[aprox. 8 p.]. Disponible en: https://www.nature.com/articles/modpathol2013135

4. Breen V, Kasabov N, Kamat AM, Jacobson E, Suttie JM, O'Sullivan PJ, et al. A holistic comparative analysis of diagnostic tests for urothelial carcinoma: a study of Cxbladder Detect, UroVision® FISH, NMP22® and cytology based on imputation of multiple datasets. BMC Med Res Methodol [Internet]. 2015 [citado 06 Mar 2020];15:[aprox. 12 p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4494166/pdf/12874_2015_Article_36.pdf

5. Faltas BM, Prandi D, Tagawa ST, Molina AM, Nanus DM, Sternberg C, et al. Clonal evolution of chemotherapy-resistant urothelial carcinoma. Nat Genet [Internet]. 2016 [citado 22 Ago 2019];48(12):[aprox. 12 p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5549141/.

6. Rouprêt M, Babjuk M, Compérat E, Zigeuner R, Sylvester RJ, Burger M, et al. European Association of Urology guidelines on upper urinary tract urothelial carcinoma: 2017 Update. Eur Urol [Internet]. 2018 [citado 06 Mar 2020];73(1):[aprox. 9 p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/28867446

7. Rouprêt M, Babjuk M, Compérat E, Zigeuner R, Sylvester RJ, Burger M, et al. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update. Eur Urology [Internet]. 2015 [citado 06 Mar 2020];68(5):[aprox. 11 p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/26188393

8. Nguyen D, Taheri D, Springer S, Cowan M, Guner G, Mendoza Rodriguez MA, et al. High prevalence of TERT promoter mutations in micropapillary urothelial carcinoma. Virchows Arch [Internet]. 2016 Oct [citado 06 Mar 2020];469(4):[aprox. 6 p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5561427/.

9. Cervantes-González ÓA, García-Nares S, Sánchez-Ramírez VW, Reyes-Arias Ó, Shuck-Bello CE. Carcinoma de uretra primario, reporte de caso y revisión de la literatura. Bol Col Mex Urol. Ene-Abr 2018;33(1):1-5.

10. Balar AV, Galsky MD, Rosenberg JE, Powles T, Petrylak DP, Bellmunt J, et al. Atezolizumab as fi rst-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial. Lancet [Internet]. 2017 [citado 06 Mar 2020];389(10064):[aprox. 23 p.]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5568632/pdf/nihms896050.pdf

11. Santana DJ, Serrano OF, Scarpetta LA. Carcinoma de cérvix estadio ib1 diagnosticado en el embarazo, reporte de un caso en el Hospital Militar Central, Bogotá [Internet]. Rev Colomb Obst Ginecol [Internet]. 2018 [citado 06 Mar 2020];69:[aprox. 3 p.]. Disponible en: http://search.ebscohost.com/login.aspx?direct=true&db=lth&AN=135653750&lang=es&site=ehost-live

12. Albino Gonçalves L de A, Magalhães Câmara F, Dallacqua Santiago JH, Almeida Gonçalves L A de, Maciel Braga M, Saint-clair Pimentel Mafra R. Carcinoma sarcomatóide de bexiga em Paciente de 43 anos sem história prévia de Tabagismo e fatores predisponentes. Braz J Surg Clin Res. 2018;23(4):45-45.

Downloads

Published

2020-05-08

How to Cite

1.
Morell-Molina E, Pardo-Yero H. Urothelial carcinoma: a case report. Arch méd Camagüey [Internet]. 2020 May 8 [cited 2025 Aug. 3];24(3):426-33. Available from: https://revistaamc.sld.cu/index.php/amc/article/view/6637

Issue

Vol. 24 No. 3 (2020)

Section

Case Reports

License

Copyright: Camagüey Medical Archive Magazine, offers immediately after being indexed in the SciELO Project; Open access to the full text of the articles under the principle of making available and free the research to promote the exchange of global knowledge and contribute to a greater extension, publication, evaluation and extensive use of the articles that can be used without purpose As long as reference is made to the primary source.

Conflicts of interest: authors must declare in a mandatory manner the presence or not of conflicts of interest in relation to the investigation presented.

(Download Statement of potential conflicts of interest)

The Revista Archivo Médico de Camagüey is under a License Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 International (CC BY 4.0).

This license allows others to distribute, to mix, to adjust and to build from its work, even for commercial purposes, as long as it is recognized the authorship of the original creation. This is the most helpful license offered. Recommended for maximum dissemination and use of licensed materials. The full license can be found at: https://creativecommons.org/licenses/